This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


1x95

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:1x95.gif|left|200px]]
+
{{Seed}}
 +
[[Image:1x95.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1x95| PDB=1x95 | SCENE= }}
{{STRUCTURE_1x95| PDB=1x95 | SCENE= }}
-
'''solution structure of the B-DNA hexamer ATGCAT complexed with MLN944, a bisphenazine anticancer drug'''
+
===solution structure of the B-DNA hexamer ATGCAT complexed with MLN944, a bisphenazine anticancer drug===
-
==Overview==
+
<!--
-
The new bisphenazine anticancer drug MLN944 is a novel cytotoxic agent with exceptional anti-tumor activity against a range of human and murine tumor models both in vitro and in vivo. MLN944 has recently entered Phase I clinical trials. Despite the structural similarity with its parent monophenazine carboxamide and acridine carboxamide anticancer compounds, MLN944 appears to work by a distinct mechanism of inhibiting DNA transcription rather than the expected mechanism of topoisomerase I and II inhibition. Here we present the first NMR structure of MLN944 complexed with d(ATGCAT)(2) DNA duplex, demonstrating a novel binding mode in which the two phenazine rings bis-intercalate at the 5'-TpG site, with the carboxamide amino linker lying in the major groove of DNA. The MLN944 molecule adopts a significantly unexpected conformation and side chain orientation in the DNA complex, with the N10 on the phenazine ring protonated at pH 7. The phenazine chromophore of MLN944 is very well stacked with the flanking DNA base pairs using the parallel base-stacking intercalation binding mode. The DNA sequence specificity and the groove recognition of MLN944 binding is determined by several site-specific hydrogen bond interactions with the central G:C base pair as well as the favorable stacking interactions with the 5'-flanking thymine. The specific binding site of MLN944 is known to be recognized by a number of important transcription factors. Our electrophoretic gel mobility shift assay results demonstrated that the c-Jun DNA binding to the AP-1 site is significantly inhibited by MLN944 in a dose-dependent manner. Thus, the exceptional biological activity of MLN944 may be due to its novel DNA binding mode leading to a unique mechanism of action.
+
The line below this paragraph, {{ABSTRACT_PUBMED_15317822}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 15317822 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_15317822}}
==About this Structure==
==About this Structure==
-
Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1X95 OCA].
+
Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1X95 OCA].
==Reference==
==Reference==
Line 32: Line 36:
[[Category: Structure]]
[[Category: Structure]]
[[Category: Transcription inhibition]]
[[Category: Transcription inhibition]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May 3 14:43:34 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 14:53:27 2008''

Revision as of 11:53, 28 July 2008

Image:1x95.png

Template:STRUCTURE 1x95

solution structure of the B-DNA hexamer ATGCAT complexed with MLN944, a bisphenazine anticancer drug

Template:ABSTRACT PUBMED 15317822

About this Structure

Full experimental information is available from OCA.

Reference

Novel DNA bis-intercalation by MLN944, a potent clinical bisphenazine anticancer drug., Dai J, Punchihewa C, Mistry P, Ooi AT, Yang D, J Biol Chem. 2004 Oct 29;279(44):46096-103. Epub 2004 Aug 17. PMID:15317822

Page seeded by OCA on Mon Jul 28 14:53:27 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/1x95"
Personal tools